Large Volume Parenteral Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Ozon Pharmaceuticals, Baxter Healthcare, BML Parenteral Drugs, Emcure Pharmaceuticals, Otsuka Pharmaceutical Inc., Beximco Pharma

Large Volume Parenteral (LVP) Market is expected to grow at a CAGR of 3.1% over the forecast period 2024-2031.

DataM Intelligence unveils its latest report on the "Large Volume Parenteral Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/large-volume-parenteral-market?sg

List of Top Key Player: B. Braun Melsungen AG, Baxter Healthcare Corporation, Fresenius Kabi AG, Pfizer, Inc., BML Parenteral Drugs, Emcure Pharmaceuticals Ltd, Otsuka Pharmaceutical Factory, Inc., Beximco Pharma, China Resources Pharmaceutical GroupCo., Ltd. and Ozon Pharmaceuticals.

Industry Developments:

USA - Industry Developments:

✅ ICU Medical and Otsuka Pharmaceutical Complete Joint Venture
In March 2025, ICU Medical and Otsuka Pharmaceutical finalized a joint venture, creating one of the largest global IV solutions manufacturing networks with an estimated combined production of 1.4 billion annual units.

✅ CDMO Investments in Europe and the US
Between February and April 2025, major contract manufacturers in the US announced large capital expenditures to boost capacity, especially in high-demand areas like biologics and high-potency small molecules.

Japan - Industry Developments:

✅ Shionogi to Acquire Torii Pharmaceutical and Akros Pharma from JT
In May 2025, Shionogi announced the acquisition of Torii Pharmaceutical and Akros Pharma from JT, reinforcing its domestic commercial infrastructure and enhancing its global footprint.

✅ Mitsubishi Tanabe Pharma Acquired by Bain Capital
In February 2025, Bain Capital acquired Mitsubishi Tanabe Pharma for $3.4 billion, aiming to fast-track drug development in Japan, especially for rare diseases.

Europe - Industry Developments:

✅ CDMO Investments in Europe and the US
Between February and April 2025, major contract manufacturers in Europe announced large capital expenditures to boost capacity, especially in high-demand areas like biologics and high-potency small molecules.

Forecast Projection:

The Global Large Volume Parenteral Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Large Volume Parenteral Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=large-volume-parenteral-market?sg

Key Segmentation:

By Volume(250 ml - 500 ml, 100 ml - 250 ml, 500 ml - 1000 ml, 1000 ml - 2000 ml)

By Application( Nutritious Injections, Vitamin B12, Isolyte M in Dextrose, Fluid Balance Injections, Hypertonic Saline (3% and 5% Sodium Chloride Injection, 5% Dextrose and Electrolyte, Therapeutic Injection)

By Type of Packaging(Bottles, Bags)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Large Volume Parenteral Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/large-volume-parenteral-market?sg

FAQ's

Q1: How fast is the Large Volume Parenteral Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 3.1% between 2024-2031, signaling strong global growth and investment potential.

Q2: Which regions are dominating the Large Volume Parenteral Market and which are fastest-growing?

A: North America is expected to hold the largest market share in the large global volume parenteral (LVP) market.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.